Abstracts

• Bortezomib: introduction

  Alessandro Corso

  https://doi.org/10.4081/hmr.v2i5.379

  288

  PDF: 271

  • PDF

• An update of the apex study

  Alessandro Corso

  https://doi.org/10.4081/hmr.v2i5.380

  328

  PDF: 1368

  • PDF

• Bortezomib-combination based therapy in relapsed-refractory myeloma patients

  Patrizia Zappasodi

  https://doi.org/10.4081/hmr.v2i5.381

  267

  PDF: 1401

  • PDF

• Bortezomib in newly diagnosed multiple myeloma patients

  Silvia Mangiacavalli

  https://doi.org/10.4081/hmr.v2i5.382

  204

  PDF: 327

  • PDF

• Frequency and characteristics of hematologic and non-hematologic Bortezomib-related toxicity

  Marzia Varettoni

  https://doi.org/10.4081/hmr.v2i5.383

  218

  PDF: 1706

  • PDF